A method for constructing a ten-gene edited xenotransplantation donor pig
The construction of ten-gene edited xenogene transplanted donor pigs through CRISPR/Cas9 and piggyBac technology solved the problem of difficulty in multi-gene editing and low clonal survival rate, achieved reduction of immune rejection and inflammatory response, extended transplant survival time, and improved gene editing Efficiency and survival rate of cloned pigs provide a better application basis for pig-human xenogenesis transplantation.
Patent Information
- Application Number
- CN202410034211.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2023-11-03
- Filing Date
- 2024-01-10
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-01-10
AI Technical Summary
The existing gene editing technology has problems in pig-human xenogene transplantation, which is difficult and inefficient in simultaneous editing of multiple genes, low survival rates of multi-gene editing cloned pigs, and uneven expression of target genes, resulting in immune rejection and inflammation. The reaction is difficult to control effectively.
CRISPR/Cas9 gene editing technology combined with piggyBac transposon technology was used to construct GTKO/β4GalNT2KO/CMAHKO/hCD39/hCD46/hCD47/hCD55/hCD59/hTBM/hEPCR ten-gene editing xenogeneic organ transplant donor pigs, and designed multiple sgRNA nuclei Glylate series and secondary editing gene targeting vectors improve gene editing success rate and survival rate of cloned pigs.
Effectively reduces the immune rejection and inflammatory response in xenogeneic organ transplantation, prolongs the transplant survival time, improves gene editing efficiency and the survival rate of cloned pigs, and provides better preclinical research and clinical research for pig-human xenogeneic organ transplantation. Basic application.
Smart Images

Figure HDA0004657066480000011 
Figure HDA0004657066480000012 
Figure HDA0004657066480000021
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of animal biotechnology, and specifically, relates to a method for constructing a ten-gene edited xenogeneic organ transplant donor pig. Background Art
[0002] Xenotransplantation has been recognized as an effective way to solve the global gap between supply and demand of human organ transplantation, and pig-human xenotransplantation has been hailed as "the next major biomedical revolution."
[0003] Xenotransplantation still needs to overcome rejection, control inflammation, regulate coagulation disorders and other problems. In order to overcome these obstacles, the genetic manipulation of xenotransplantation mainly includes two purposes: (I) inactivation of pig-derived xenoantigens; (II) transgenic expression of human protective proteins, including coagulation regulatory factors, complement regulatory factors, cellular immune response factors, anti-apoptosis and anti-inflammatory factors. In recent years, with the advancement of gene editing technology, various gene-edited donor pigs have been reported. The results of subclinical studies on pig-human xenotransplantation have also effectively proved that adding some other xenoantigen gene knockouts and humanized gene expression on the basis of GGTA1 gene knockout can help reduce the immune rejection caused by xenotransplantation. For these major xenoantigen genes and a large number of humanized gene expression modifications, the existing gene editing technology applications generally have common problems such as difficulty in editing multiple genomes at the same time, low efficiency, low survival rate of multi-gene edited cloned pigs, and uneven expression of target genes. Summary of the invention
[0004] In view of the above problems, the present invention provides a method for constructing a ten-gene edited xenotransplantation donor pig. The method targets the common problem of immune rejection reaction in pig-human xenotransplantation, utilizes CRISPR / Cas9 gene editing technology and piggyBac transposon technology, and combines somatic cell cloning technology to construct a ten-gene edited xenotransplantation donor pig of GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR, which is of great value in promoting the clinical application of pig-human xenotransplantation.
[0005] To achieve the above object, the present invention is implemented by the following technical solutions:
[0006] In a first aspect, the present invention provides sgRNA targeting vectors of GGTA1, β4GalNT2 and CMAH genes. The sgRNA targeting vectors of GGTA1, β4GalNT2 and CMAH genes are constructed by using CRISPR / Cas9 gene editing technology. The sgRNA action sites are located in the third exon of the porcine GGTA1 gene, the second exon of the β4GalNT2 gene and the fourth exon of the CMAH gene.
[0007] Further, the above-mentioned GGTA1, β4GalNT2, CMAH gene sgRNA targeting vectors include: GGTA1-sgRNA1, GGTA1-sgRNA2, β4GalNT2-sgRNA1, β4GalNT2-sgRNA2, β4GalNT2-sgRNA3, CMAH-sgRNA1 and CMAH-sgRNA2; the nucleotide sequence of GGTA1-sgRNA1 is shown in SEQ ID NO:1; the nucleotide sequence of GGTA1-sgRNA2 is shown in SEQ ID NO:2; the nucleotide sequence of β4GalNT2-sgRNA1 is shown in SEQ ID NO:5; the nucleotide sequence of β4GalNT2-sgRNA2 is shown in SEQ ID NO:6; the nucleotide sequence of β4GalNT2-sgRNA3 is shown in SEQ ID NO:7; the nucleotide sequence of CMAH-sgRNA1 is shown in SEQ ID NO:8; the nucleotide sequence of CMAH-sgRNA2 is shown in SEQ ID NO: As shown in IDNO:9.
[0008] Furthermore, the backbone vector connected to the above-mentioned GGTA1, β4GalNT2, and CMAH gene sgRNA targeting vectors is PX458-sgRNA-EGFP (Addgene no: 112220).
[0009] The second aspect of the present invention provides a recombinant plasmid for knocking out the GGTA1, β4GalNT2 and CMAH genes in the pig genome, and the nucleotide sequence thereof is shown in SEQ ID NO:10.
[0010] The third aspect of the present invention provides a GGTA1 gene sgRNA targeting vector, the sgRNA action site is located in the 8th exon of the pig GGTA1 gene, the nucleotide sequence of GGTA1-sgRNA3 is shown in SEQ ID NO: 3; the nucleotide sequence of GGTA1-sgRNA4 is shown in SEQ ID NO: 4, which are respectively connected to the backbone vector PX458-sgRNA-EGFP, and the gene number of the backbone vector is (Addgene no: 112220).
[0011] The fourth aspect of the present invention provides a recombinant plasmid for knocking out the GGTA1 gene in the pig genome, and the nucleotide sequence of the recombinant plasmid is shown in SEQ ID NO:19.
[0012] In a fifth aspect, the present invention provides an expression vector for transferring humanized genes of hCD39, hCD46, hCD55, hCD59 and hTBM, the nucleotide sequence of which is shown in SEQ ID NO:18.
[0013] Furthermore, the nucleotide sequence of hCD39 is shown in SEQ ID NO:11; the nucleotide sequence of hCD46 is shown in SEQ ID NO:12; the nucleotide sequence of hCD55 is shown in SEQ ID NO:14; the nucleotide sequence of hCD59 is shown in SEQ ID NO:15; and the nucleotide sequence of hTBM is shown in SEQ ID NO:16.
[0014] The sixth aspect of the present invention provides an hCD47 and hEPCR humanized gene transfer expression vector, the nucleotide sequence of which is shown in SEQ ID NO:20.
[0015] Furthermore, the nucleotide sequence of hCD47 is shown in SEQ ID NO:13; and the nucleotide sequence of hEPCR is shown in SEQ ID NO:17.
[0016] The seventh aspect of the present invention provides GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR+gene-edited porcine fetal fibroblast cell line.
[0017] 1) The above-mentioned GGTA1, β4GalNT2, CMAH gene sgRNA targeting vectors or recombinant plasmids for knocking out GGTA1, β4GalNT2, CMAH genes in the pig genome, and hCD39, hCD46, hCD55, hCD59, hTBM humanized genes are transferred into expression vectors and co-transfected into wild-type porcine fetal fibroblasts under the action of transposase. The eight-gene edited positive monoclonal cell line obtained by screening is the GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM eight-gene edited porcine fibroblast cell line, which is used as donor cells for somatic cell nuclear transplantation to construct the GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM eight-gene edited porcine fetal fibroblast cell line.
[0018] 2) The above-mentioned GGTA1 gene sgRNA vector or the recombinant plasmid for knocking out the GGTA1 gene in the pig genome, and the hCD47 and hEPCR humanized genes are transferred into the expression vector and co-transfected into the GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM eight-gene-edited pig fetal fibroblast cell line under the action of transposase, and ten-gene-edited positive monoclonal cell lines are obtained after screening, namely the GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR ten-gene-edited pig fetal fibroblast cell line.
[0019] The eighth aspect of the present invention provides a method for constructing a ten-gene edited xenotransplantation donor pig, the specific steps of which are:
[0020] (1) Construction of recombinant plasmids for knocking out GGTA1, β4GalNT2, and CMAH genes in the pig genome based on the CRISPR / Cas9 gene editing system
[0021] sgRNA targeting vectors were designed for the exon 3 of the GGTA1 gene, the exon 2 of the β4GalNT2 gene, and the exon 4 of the CMAH gene in the pig genome, and were connected to the backbone vector PX458-sgRNA-EGFP (Addgene no: 112220), respectively, to obtain recombinant plasmids for knocking out the GGTA1, β4GalNT2, and CMAH genes in the pig genome.
[0022] The sgRNA targeting vector includes GGTA1-sgRNA1, GGTA1-sgRNA2, β4GalNT2-sgRNA1, β4GalNT2-sgRNA2, β4GalNT2-sgRNA3, CMAH-sgRNA1, and CMAH-sgRNA2; wherein the nucleotide sequence of GGTA1-sgRNA1 is shown in SEQ ID NO:1; the nucleotide sequence of GGTA1-sgRNA2 is shown in SEQ ID NO:2; the nucleotide sequence of β4GalNT2-sgRNA1 is shown in SEQ ID NO:5; the nucleotide sequence of β4GalNT2-sgRNA2 is shown in SEQ ID NO:6; the nucleotide sequence of β4GalNT2-sgRNA3 is shown in SEQ ID NO:7; the nucleotide sequence of CMAH-sgRNA1 is shown in SEQ ID NO:8; and the nucleotide sequence of CMAH-sgRNA2 is shown in SEQ ID NO:9.
[0023] The nucleotide sequence of the recombinant plasmid used to knock out the GGTA1, β4GalNT2, and CMAH genes in the pig genome is shown in SEQ ID NO:10.
[0024] (2) Based on the piggyBac transposon system, humanized gene transfer expression vectors of hCD39, hCD46, hCD55, hCD59, and hTBM were constructed, and the nucleotide sequence thereof is shown in SEQ ID NO:18.
[0025] Furthermore, the nucleotide sequence of hCD39 is shown in SEQ ID NO:11; the nucleotide sequence of hCD46 is shown in SEQ ID NO:12; the nucleotide sequence of hCD55 is shown in SEQ ID NO:14; the nucleotide sequence of hCD59 is shown in SEQ ID NO:15; and the nucleotide sequence of hTBM is shown in SEQ ID NO:16.
[0026] (3) Based on the CRISPR / Cas9 gene editing system, a secondary editing GGTA1 gene sgRNA targeting vector was constructed and connected to the backbone vector PX458-sgRNA-EGFP (Addgene no: 112220).
[0027] The GGTA1 gene sgRNA targeting vector includes GGTA1-sgRNA3 and GGTA1-sgRNA4, the nucleotide sequence of GGTA1-sgRNA3 is shown in SEQ ID NO:3; the nucleotide sequence of GGTA1-sgRNA4 is shown in SEQ ID NO:4, and the nucleotide sequence of the recombinant plasmid for knocking out the GGTA1 gene in the pig genome is shown in SEQ ID NO:19.
[0028] (4) Based on the piggyBac transposon system, hCD47 and hEPCR humanized gene transfer expression vectors were constructed, and the nucleotide sequence thereof is shown in SEQ ID NO:20.
[0029] Furthermore, the nucleotide sequence of hCD47 is shown in SEQ ID NO:13; and the nucleotide sequence of hEPCR is shown in SEQ ID NO:17.
[0030] (5) Construction of GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR ten gene-edited porcine fibroblast cell line
[0031] 1) The recombinant plasmids for knocking out the GGTA1, β4GalNT2, and CMAH genes in the pig genome and the humanized genes of hCD39, hCD46, hCD55, hCD59, and hTBM were transferred into expression vectors and co-transfected into wild-type porcine fetal fibroblast cell lines under the action of transposase. After monoclonal cell genotype identification, the eight-gene-edited porcine fibroblast cell line GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM was screened and obtained, and used as donor cells for somatic cell nuclear transplantation to construct the eight-gene-edited porcine fetus GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM and establish a fetal fibroblast cell line.
[0032] 2) The recombinant plasmid used to knock out the GGTA1 gene in the pig genome and the humanized genes of hCD47 and hEPCR were transferred into the expression vector and co-transfected into the eight-gene-edited pig fetal fibroblast cell line GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM under the action of transposase. After single-cell cloning genotype identification, the ten-gene-edited pig fibroblast cell line GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR was obtained.
[0033] Furthermore, the blood type of the wild-type porcine fetal fibroblast cell line is O type, which has good compatibility and can reduce the immune rejection reaction caused by blood type incompatibility in xenotransplantation.
[0034] Furthermore, the above transfection method includes liposome transfection or electrofection; preferably electrofection.
[0035] (6) Somatic cell nuclear transfer and embryo transfer
[0036] Using GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR+gene-edited porcine fibroblast cell line as donor cells, somatic cell nuclear transplantation was performed to construct GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEP CR+gene-edited porcine cloned embryos, which were further transplanted into estrus surrogate sows for development. GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR+gene-edited cloned pigs were obtained by natural delivery after 114 days of gestation, or the fetuses were removed during pregnancy for genotype identification and establishment of fibroblast cell lines.
[0037] Furthermore, the above-mentioned donor cells can be GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR+gene-editing positive monoclonal pig fibroblasts or cloned fetal fibroblasts or cloned pig fibroblasts, preferably cloned pig fetal fibroblasts.
[0038] (7) Genotyping and phenotypic analysis of cloned pigs
[0039] The genomic DNA of the cloned piglets was extracted, and the genotype of the cloned pigs was identified by PCR, T7ENI, and Sanger sequencing techniques. The gene mRNA and protein expression levels in the tissues and organs of the cloned piglets were detected by Western blotting, immunofluorescence staining, flow cytometry, HE staining, and cross-matching experimental molecular biology techniques, and GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR ten gene-edited cloned pigs were obtained.
[0040] (8) Through continuous cloning technology, GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR ten gene-edited cloned pigs were mass-produced.
[0041] The above-mentioned GGTA1, β4GalNT2, CMAH gene sgRNA targeting vectors, and / or, recombinant plasmids for knocking out the GGTA1, β4GalNT2, CMAH genes in the pig genome, and / or, hCD39, hCD46, hCD55, hCD59, hTBM humanized gene transfer expression vectors, and / or, GGTA1 gene sgRNA targeting vectors, and / or, recombinant plasmids for knocking out the GGTA1 gene in the genome, and / or, hCD47, hEPCR humanized gene transfer expression vectors, and / or, GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEP CR ten-gene-edited pig fetal fibroblast cell line, and / or, a method for constructing a ten-gene-edited xenogeneic organ transplant donor pig is used in the field of biomedical research.
[0042] Inactivation of GGTA1 (producing α-Gal antigen), CMAH (producing Neu5Gc antigen) and β4GalNT2 (producing Sda antigen) in pigs can effectively reduce the occurrence of hyperacute and acute rejection reactions mediated by antigen-antibody in xenotransplantation of kidneys. Knocking out CMAH and β4GalNT2 genes based on GGTA1 gene inactivation will more effectively alleviate immune rejection after xenotransplantation. Compared with cells with single GGTA1 gene and GGTA1 / CMAH gene deficiency, GGTA1 / CMAH / β4GALNT2 triple-gene knockout pig cells have significantly reduced binding to xenogeneic IgM and IgG in vitro, suggesting that GGTA1 / CMAH / β4GalNT2 triple-gene knockout pigs have lower immunogenicity and can better promote the long-term survival of xenotransplants.
[0043] Human complement regulatory proteins (CD55, CD59, CD46), thrombomodulin (CD39, TBM, EPCR), cellular immune response factors (CD47) and anti-apoptosis regulators are expressed in xenotransplant donor pigs to regulate the dysregulation of complement, coagulation and inflammatory pathways caused by species incompatibility. Compared with GTKO single-gene edited pigs, the survival time of GTKO / hCD55 gene-edited pig kidneys transplanted into non-human primates can reach 499 days, indicating that while knocking out the xenoantigen gene, the introduction of human complement regulatory proteins such as CD46, CD55, and CD59 into the pig can effectively alleviate the rejection reaction caused by complement activation and prolong the survival time of xenotransplanted kidneys.
[0044] The research results effectively proved that knocking out CMAH and β4GalNT2 xenoantigen genes and overexpressing humanized genes based on GGTA1 inactivation can help reduce the immune rejection reaction caused by xenotransplantation and promote the long-term survival of xenografts.
[0045] Beneficial effects of the present invention:
[0046] 1. The present invention designs multiple different sgRNA nucleotide series for gene knockout targeting vectors and constructs expression vectors for simultaneous editing of multiple genes. While improving the success rate of gene targeting, it overcomes the common technical difficulties of CRISPR / Cas9 technology, such as low efficiency of multi-gene editing, low birth efficiency of cloned pigs after multi-gene modification, and difficulty in survival.
[0047] 2. The present invention constructs a secondary editing gene targeting vector, which overcomes the problem of low efficiency of existing multi-gene editing. Secondary editing is performed on the basis of eight-gene editing to construct a ten-gene edited fibroblast cell line, which improves the success rate of gene editing and lays a theoretical foundation for multi-gene combination modification.
[0048] 3. The present invention discloses a method for constructing a ten-gene-edited xenotransplantation donor pig, which overcomes the problems of immune rejection, inflammatory response and coagulation disorder generated in the process of xenotransplantation by inactivating three carbohydrate antigen genes in the pig genome and overexpressing seven humanized genes in the pig genome. The ten-gene-edited xenotransplantation donor pig of GTKO / β4GalNT2KO / CMAHKO / hCD46 / hCD55 / hCD59 / hCD39 / hTBM constructed by the present invention solves the common problems of hyperacute immune rejection, antigen-antibody-mediated immune rejection, coagulation disorder and receptor immune cell activation in the process of xenotransplantation to the greatest extent, laying a foundation for the further development of donor pigs suitable for xenotransplantation of different tissues and organs such as heart, kidney, liver and skin, and has important prospects for preclinical research on pig-non-human primate xenotransplantation and clinical application of pig-human xenotransplantation. BRIEF DESCRIPTION OF THE DRAWINGS
[0049] Figure 1 Schematic diagram of the construction of GTKO / CMAHKO / β4GalNT2KO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM gene editing vector;
[0050] Figure 1 A in the middle is a schematic diagram of GGTA1 gene targeting;
[0051] Figure 1 Middle B is a schematic diagram of CMAH gene targeting;
[0052] Figure 1 Center C is a schematic diagram of β4GalNT2 gene targeting;
[0053] Figure 1 D in the middle is a schematic diagram of the construction of hCD39 / hCD46 / hCD55 / hCD59 / hTBM gene editing vector;
[0054] Figure 2 This is the Sanger sequencing result of the single-cell cloned GGTA1 gene;
[0055] Figure 3 Sanger sequencing results of CMAH gene in single cell clones;
[0056] Figure 4 The results of Sanger sequencing of the β4GalNT2 gene in single-cell clones;
[0057] Figure 5 The results of PCR identification of hCD39 / hCD46 / hCD55 / hCD59 / hTBM genes transferred into single cell clones;
[0058] Figure 6 The eight genes of GTKO / CMAHKO / β4GalNT2KO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM were edited and cloned into pig fetuses;
[0059] Figure 7 PCR identification results of hCD39 / hCD46 / hCD55 / hCD55 / hTBM gene transfer into cloned pig fetus;
[0060] Figure 8 The results of PCR identification of gene knockout in cloned pig fetus GTKO / CMAHKO / β4GalNT2KO;
[0061] Fig. 9 The results of Sanger sequencing for the knockout of GTKO / CMAHKO / β4GalNT2KO genes in cloned pig fetuses;
[0062] Fig.10 Schematic diagram for the construction of GTKO / hCD47 / hEPCR gene editing vector;
[0063] Fig.10 A in the middle is a schematic diagram of secondary targeting of the GGTA1 gene;
[0064] Fig.10 Middle B is a schematic diagram of the construction of the hCD47 / hEPCR gene editing vector.
[0065] Fig.11 Secondary editing of GGTA1 gene PCR identification results for single cell cloning;
[0066] Fig.12 Secondary editing of Sanger sequencing results of GGTA1 gene PCR products for single cell cloning;
[0067] Fig.13PCR identification results of hCD47 / hEPCR gene transferred into single cell clone;
[0068] Fig.14 The PCR identification results of GTKO / CMAHKO / β4GalNT2KO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR and gene-edited cloned pig fetuses;
[0069] Fig.14 A in the middle is a photo of five viable cloned pig fetuses;
[0070] Fig.14 Middle B is the PCR identification result of GGTA1 gene;
[0071] Fig.14 Middle C is the result of PCR identification of CMAH gene;
[0072] Fig.14 Middle D is the PCR identification result of β4GalNT2 gene;
[0073] Fig.14 Middle E is the hCD47 gene PCR identification result;
[0074] Fig.14 Middle F is the hEPCR gene PCR identification result;
[0075] Fig.14 Middle G is the hCD55 / hCD59 gene PCR identification result;
[0076] Fig.14 Middle H is the hCD46 gene PCR identification result;
[0077] Fig.14 Middle I is the hCD39 / hTBM gene PCR identification result;
[0078] Fig.15 Secondary editing of the GGTA1 gene Sanger sequencing results for 5 fetuses;
[0079] Fig.16 GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR ten gene editing living cloned pigs;
[0080] Fig.17 PCR identification results of GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR ten gene-edited cloned pigs;
[0081] Fig.17 A in the middle is the PCR identification result of GGTA1 gene;
[0082] Fig.17 Middle B is the result of PCR identification of CMAH gene;
[0083] Fig.17 Middle C is the PCR identification result of β4GalNT2 gene;
[0084] Fig.17 D in the middle is the hCD47 gene PCR identification result;
[0085] Fig.17 E in the middle is the hEPCR gene PCR identification result;
[0086] Fig.17 F in the middle is the hCD55 / hCD59 gene PCR identification result;
[0087] Fig.17 Middle G is the hCD46 gene PCR identification result;
[0088] Fig.17 Middle H is the hTBM / hCD39 gene PCR identification result;
[0089] Fig.18 The results of Sanger sequencing for editing the GGTA1 gene of cloned pigs;
[0090] Fig.19 To clone the expression level of hCD39 gene mRNA in pig heart, kidney, liver and lung tissues;
[0091] Fig. 20 To clone the expression level of hCD46 gene mRNA in pig heart, kidney, liver and lung tissues;
[0092] Fig.21 To clone the expression level of hCD55 gene mRNA in pig heart, kidney, liver and lung tissues;
[0093] Fig. 22 To clone the expression level of hCD59 gene mRNA in pig heart, kidney, liver and lung tissues;
[0094] Fig.23 To clone the expression level of hCD47 gene mRNA in pig heart, kidney, liver and lung tissues;
[0095] Fig.24 To clone the expression level of hEPCR gene mRNA in pig heart, kidney, liver and lung tissues;
[0096] Fig.25To clone the expression level of hTBM gene mRNA in pig heart, kidney, liver and lung tissues;
[0097] Fig.26 The results of immunofluorescence detection of GTKO / β4GalNT2KO / CMAHKO / hCD39 / hTBM gene expression levels in cloned pig tissues;
[0098] Fig. 27 These are the results of immunofluorescence detection of hCD46 / hCD47 / hCD55 / hCD59 / hEPCR gene expression levels in cloned pig tissues. DETAILED DESCRIPTION
[0099] In order to make the objectives, technical solutions and beneficial effects of the present invention clearer, the preferred embodiments of the present invention will be described in detail below to facilitate understanding by technicians.
[0100] Example 1: Construction of ten gene editing targeting vectors
[0101] (1) Construction of GTKO / β4GalNT2KO / CMAHKO triple gene knockout expression vector based on CRISPR / Cas9 gene editing technology
[0102] The nucleotide sequences of porcine GGTA1 (Gene ID: 396733), β4GalNT2 (Gene ID: 100621328) and CMAH (Gene ID: 396918) genes were obtained by searching the NCBI database. Figure 1 A), exon 2 of β4GalNT2 gene ( Figure 1 C), exon 4 of the CMAH gene ( Figure 1 In Figure B), online software (http: / / crispor.tefor.net / ) was used to design and screen targeting sgRNA sites, and GGTA1-sgRNA1 (SEQ ID NO: 1), GGTA1-sgRNA2 (SEQ ID NO: 2), β4GalNT2-sgRNA1 (SEQ ID NO: 5), β4GalNT2-sgRNA2 (SEQ ID NO: 6), β4GalNT2-sgRNA3 (SEQ ID NO: 7), and CMAH sgRNA (SEQ ID NO: 4) were obtained, and the sgRNA sequences were connected to the backbone vector PX458-sgRNA-EGFP (Addgene no: 112220) to obtain the recombinant plasmids of GGTA1, β4GalNT2-sgRNA, and CMAH genes (SEQ ID NO: 10).
[0103] (2) Construction of humanized gene transfer expression vectors for hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR based on the piggyBac system
[0104] Based on the piggyBac transposon system, humanized gene transfer expression vectors for hCD39, hCD46, hCD55, hCD59, and hTBM and humanized gene transfer expression vectors for hCD47 and hEPCR were constructed; the nucleotide sequence of hCD39 is shown in SEQ ID NO: 11; the nucleotide sequence of hCD46 is shown in SEQ ID NO: 12; the nucleotide sequence of hCD47 is shown in SEQ ID NO: 13; the nucleotide sequence of hCD55 is shown in SEQ ID NO: 14; the nucleotide sequence of hCD59 is shown in SEQ ID NO: 15; the nucleotide sequence of hTBM is shown in SEQ ID NO: 16; the nucleotide sequence of hEPCR is shown in SEQ ID NO: 17. They were connected to the backbone vector PiggyBac transposon, and their nucleotide sequences are shown in SEQ ID NO: 18.
[0105] Further targeting the 8th exon of the porcine GGTA1 gene, secondary editing GGTA1 gene targeting vectors GGTA1-sgRNA3 (SEQ ID NO: 3) and GGTA1-sgRNA4 (SEQ ID NO: 4) were constructed and connected to the backbone vector PX458-sgRNA-EGFP (Addgene no: 112220). The nucleotide sequence of the recombinant plasmid is shown in SEQ ID NO: 19; the hCD47 / hEPCR humanized gene was transferred into the expression vector, and its nucleotide sequence is shown in SEQ ID NO: 20.
[0106] Example 2: Construction of ten-gene edited cloned pigs
[0107] Targeting exon 3 of porcine GGTA1 gene (Gene ID: 396733) Figure 1 A), exon 2 of β4GalNT2 gene (GeneID: 100621328) Figure 1 C), exon 4 of CMAH gene (GeneID: 396918) Figure 1B), online software (http: / / crispor.tefor.net / ) was used to design and screen targeting sgRNA sites, and GGTA1-sgRNA1 (SEQ ID NO: 1), GGTA1-sgRNA2 (SEQ ID NO: 2), β4GalNT2-sgRNA1 (SEQ ID NO: 5), β4GalNT2-sgRNA2 (SEQ ID NO: 6), β4GalNT2-sgRNA3 (SEQ ID NO: 7), CMAH-sgRNA1 (SEQ ID NO: 8), CMAH–sgRNA2 (SEQ ID NO: 9) targeting vectors were obtained respectively ( Figure 1 AC), and the sgRNA sequence was connected to the backbone vector PX458-sgRNA-EGFP (Addgene no: 112220) to obtain a recombinant plasmid (SEQ ID NO: 10) for knocking out the GGTA1, β4GalNT2, and CMAH genes in the pig genome. Based on the piggyBac system, the first step was to connect the nucleotide sequences of the hCD39 (SEQ ID NO: 11), hCD46 (SEQ ID NO: 12), hCD55 (SEQ ID NO: 14), hCD59 (SEQ ID NO: 15), and hTBM (SEQ ID NO: 16) genes to the piggyBac transposon vector ( Figure 1 D), construct hCD39 / hCD46 / hCD55 / hCD59 / hTBM humanized gene transfer expression vector (SEQ ID NO: 18) ( Figure 1 D); the second step is to construct the secondary editing GGTA1 gene targeting vector GGTA1-sgRNA3 (SEQ ID NO: 3), GGTA1-sgRNA4 (SEQ ID NO: 4) for the 8th exon of the porcine GGTA1 gene ( Fig.10 A), and connected to the backbone vector PX458-sgRNA-EGFP (Addgene no: 112220), the nucleotide sequence of the recombinant plasmid is shown in SEQ ID NO: 19; hCD47 (SEQ ID NO: 8), hEPCR (SEQ ID NO: 12) humanized genes were transferred into the expression vector, the nucleotide sequence of which is shown in SEQ ID NO: 20 ( Fig.10 (B).
[0108] The GGTA1, β4GalNT2, and CMAH gene sgRNA targeting vectors and the hCD39, hCD46, hCD55, hCD59, and hTBM humanized genes were transferred into expression vectors and co-transfected into wild-type porcine fetal fibroblast cell lines under the action of transposase. After 48 hours of puromycin maintenance and selection, a total of 49 single cell clones were obtained after extreme dilution culture ( Figure 5 ), and the genotyping results showed that 10 single cell clones had GGTA1 gene mutations ( Figure 2 ), 4 single cell clones had CMAH gene mutations ( Figure 3) , 6 single cell clones had β4GalNT2 gene mutation ( Figure 4 ), successfully obtained 4 GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM eight-gene editing positive monoclonal cell lines, used C2#, C3#, C4#, and C5# positive monoclonal cell lines as donor cells for somatic cell nuclear transplantation to construct cloned embryos, which were transplanted into estrus surrogate sows, and the fetuses were removed at 33 days of pregnancy ( Figure 6 ) were used for genotyping, and the results showed that the eight-gene edited cloned pig fetus was GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM ( Figure 7-9 ) and establish a fetal fibroblast cell line.
[0109] Further targeting the 8th exon of the porcine GGTA1 gene (Gene ID: 396733), the online software (http: / / crispor.tefor.net / ) was used to design and screen the GGTA1 gene secondary targeting sgRNA site and connect the sgRNA sequence to the backbone vector to obtain PX458-GGTA1-sgRNA3 / 4 (SEQ ID NO: 19) ( Fig.10 A), based on the piggyBac system, the hCD47 and hEPCR humanized gene nucleotide sequences were connected to the piggyBac transposon vector ( Fig.10 (B), construct hCD47 and hEPCR humanized genes and transfer them into expression vector (SEQ ID NO: 20).
[0110] The secondary editing GGTA1 gene sgRNA targeting vector and hCD47, hEPCR humanized gene transfer expression vector were co-transfected into No. 1 GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM eight gene editing cloned porcine fetal fibroblasts under the action of transposase. After 48 hours of puromycin maintenance screening, 58 single cell clones were obtained after extreme dilution culture and GGTA1 gene PCR amplification was performed ( Fig.11 ), and 16 single-cell clones were selected for Sanger sequencing. The results showed that 4 single-cell clones were GGTA1 gene biallelic mutations ( Fig.12 ), 15 single cell clones were successfully transferred with hCD47 / hEPCR ( Fig.13 ), and then used C3# positive monoclonal cell line as donor cells to construct cloned embryos by somatic cell nuclear transplantation, and then transplanted them into estrus surrogate sows. Five fetuses were removed at 33 days of gestation ( Fig.14 A) Genotyping showed that GGTA1 ( Fig.14 CMAH( Fig.14 Middle C), β4GalNT2 ( Fig.14 D) gene mutation, GGTA1 gene is a biallelic mutation ( Fig.15 ), hCD47( Fig.14 Chinese E), hEPCR ( Fig.14 Middle F), hCD55 / hCD59 ( Fig.14 Middle G), hCD46 ( Fig.14 hCD39 / hTBM ( Fig.14 The number of 100% successful gene editing of cloned pig fetuses was 100%, and the GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR+ gene-edited pig fetal fibroblast cell line was established. The 3 GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR+ gene-edited pig fetal fibroblast cell line was used as donor cells for somatic cell nuclear transplantation to construct cloned embryos, which were transplanted into 49 surrogate sows. After 114 days, 64+ gene-edited cloned piglets were successfully delivered, 35 of which survived, with a survival rate of 54.69% ( Fig.16 ).
[0111] Example 3: Genotyping and phenotypic analysis of ten gene-edited cloned pigs
[0112] The genotype of the cloned pigs was identified and the results showed that all of them were GTKO ( Fig.17 Middle A, Fig.18 )、β4GalNT2KO( Fig.17 C), CMAHKO( Fig.17 Middle B), hCD39 ( Fig.17 hCD46( Fig.17 Middle G), hCD47 ( Fig.17 Middle D), hCD55( Fig.17 Middle F), hCD59 ( Fig.17 Middle F), hTBM( Fig.17 hEPCR( Fig.17 Middle E) Ten-gene edited cloned pigs. Human umbilical cord endothelial cells were used as positive controls, and q-PCR was used to detect the expression of seven humanized genes in the heart, kidney and liver tissues of three ten-gene edited piglets. Compared with wild-type pigs, hCD39 ( Fig.19 )、hCD46( Fig. 20 )、hCD55( Fig.21 )、hCD59( Fig. 22 )、hCD47( Fig.23 )、hEPCR( Fig.24 )、hTBM( Fig.25 ) gene mRNA levels were significantly increased. Immunofluorescence staining of four ten-gene-edited cloned pigs was used to verify the knockout of three xenoantigens and the expression of seven humanized proteins in the cloned pig tissues. Compared with the wild type, the three carbohydrate antigens GGTA1, CMAH, and β4GalNT2 genes in the ten-gene-edited pig tissues were successfully inactivated ( Fig.26 ), hTBM / hCD39( Fig.26 ), hCD46 / hCD47 / hCD55 / hCD59 / hEPCR( Fig. 27 ) were expressed, indicating that GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM
[0113] / hEPCR+gene-edited cloned pig was successfully constructed.
[0114] In the embodiment, in view of the common problem of immune rejection in xenotransplantation, the ten-gene edited xenotransplantation donor pig constructed by the present invention improves the production efficiency and survival rate of cloned pigs while improving the efficiency of multi-gene combination modification. Next, based on the ten-gene edited xenotransplantation donor pig, different gene editing strategies can be adopted to modify related genes in view of the scientific problems faced by xenotransplantation of different organs, which has important application value for developing effective xenotransplantation donor pigs through multi-gene combination modification.
[0115] Finally, it should be noted that the above preferred embodiments are only used to illustrate the technical solutions of the present invention rather than to limit it. Although the present invention has been described in detail through the above preferred embodiments, those skilled in the art should understand that various changes can be made in form and details without departing from the scope defined by the claims of the present invention.
Claims
1. GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR+gene-edited porcine fetal fibroblast cell line, characterized by: The preparation method of the ten-gene edited porcine fetal fibroblast cell line is as follows: 1) The sgRNA targeting vectors of GGTA1, β4GalNT2, and CMAH genes or the recombinant plasmids for knocking out the GGTA1, β4GalNT2, and CMAH genes in the pig genome, and the humanized genes of hCD39, hCD46, hCD55, hCD59, and hTBM were transferred into expression vectors and co-transfected into wild-type porcine fetal fibroblasts under the action of transposase. The eight-gene-edited positive monoclonal cell line obtained by screening was the GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM eight-gene-edited porcine fibroblast cell line, which was used as donor cells for somatic cell nuclear transplantation to construct the GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM eight-gene-edited porcine fetal fibroblast cell line; The GGTA1, β4GalNT2, and CMAH gene sgRNA targeting vectors are constructed using CRISPR / Cas9 gene editing technology, and the sgRNA action sites are located in the third exon of the porcine GGTA1 gene, the second exon of the β4GalNT2 gene, and the fourth exon of the CMAH gene; The nucleotide sequence of the recombinant plasmid for knocking out the GGTA1, β4GalNT2, and CMAH genes in the pig genome is shown in SEQ ID NO: 10; The hCD39, hCD46, hCD55, hCD59, and hTBM humanized gene transfer expression vector is constructed based on the piggyBac transposon system, and the nucleotide sequence of the hCD39, hCD46, hCD55, hCD59, and hTBM humanized gene transfer expression vector is shown in SEQ ID NO: 18; 2) The GGTA1 gene sgRNA targeting vector or the recombinant plasmid for knocking out the GGTA1 gene in the genome, and the hCD47 and hEPCR humanized genes were transferred into the expression vector and co-transfected into the GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM eight-gene edited porcine fetal fibroblast cell line under the action of transposase, and ten-gene edited positive monoclonal cell lines were obtained after screening, namely the GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR ten-gene edited porcine fetal fibroblast cell line; The GGTA1 gene sgRNA targeting vector, the sgRNA action site is located in the 8th exon of the pig GGTA1 gene, the sgRNA targeting vector includes: GGTA1-sgRNA3 and GGTA1-sgRNA4; the nucleotide sequence of GGTA1-sgRNA3 is shown in SEQ ID NO:3; the nucleotide sequence of GGTA1-sgRNA4 is shown in SEQ ID NO:4, which are respectively connected to the backbone vector PX458-sgRNA-EGFP, and the gene serial number of the backbone vector is: Addgene no: 112220; The nucleotide sequence of the recombinant plasmid for knocking out the GGTA1 gene in the genome is shown in SEQ ID NO: 19; The nucleotide sequence of the hCD47 and hEPCR humanized genes transferred into the expression vector is shown in SEQ ID NO:
20.
2. The GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR+gene-edited porcine fetal fibroblast cell line according to claim 1, characterized in that: The GGTA1, β4GalNT2, and CMAH gene sgRNA targeting vectors include: GGTA1-sgRNA1, GGTA1-sgRNA2, β4GalNT2-sgRNA1, β4GalNT2-sgRNA2, β4GalNT2-sgRNA3, CMAH-sgRNA1, and CMAH-sgRNA2; the nucleotide sequence of GGTA1-sgRNA1 is shown in SEQ ID NO: 1; the nucleotide sequence of GGTA1-sgRNA2 is shown in SEQ ID NO: 2; the nucleotide sequence of β4GalNT2-sgRNA1 is shown in SEQ ID NO: 5; the nucleotide sequence of β4GalNT2-sgRNA2 is shown in SEQ ID NO: 6; the nucleotide sequence of β4GalNT2-sgRNA3 is shown in SEQ ID NO: 7; the nucleotide sequence of CMAH-sgRNA1 is shown in SEQ ID NO: 8; the nucleotide sequence of CMAH-sgRNA2 is shown in SEQ ID NO:
9.
3. A method for constructing a ten-gene edited xenotransplantation donor pig, characterized in that: The specific steps are: (1) Construction of recombinant plasmids for knocking out GGTA1, β4GalNT2, and CMAH genes in the pig genome based on the CRISPR / Cas9 gene editing system Targeting the exon 3 of the GGTA1 gene, the exon 2 of the β4GalNT2 gene, and the exon 4 of the CMAH gene in the pig genome, sgRNA targeting vectors were designed and connected to the backbone vectors, respectively, to obtain recombinant plasmids for knocking out the GGTA1, β4GalNT2, and CMAH genes in the pig genome; The sgRNA targeting vector includes GGTA1-sgRNA1, GGTA1-sgRNA2, β4GalNT2-sgRNA1, β4GalNT2-sgRNA2, β4GalNT2-sgRNA3, CMAH-sgRNA1, and CMAH-sgRNA2; wherein the nucleotide sequence of GGTA1-sgRNA1 is shown in SEQ ID NO: 1; the nucleotide sequence of GGTA1-sgRNA2 is shown in SEQ ID NO: 2; the nucleotide sequence of β4GalNT2-sgRNA1 is shown in SEQ ID NO: 5; the nucleotide sequence of β4GalNT2-sgRNA2 is shown in SEQ ID NO: 6; the nucleotide sequence of β4GalNT2-sgRNA3 is shown in SEQ ID NO: 7; the nucleotide sequence of CMAH-sgRNA1 is shown in SEQ ID NO: 8; the nucleotide sequence of CMAH-sgRNA2 is shown in SEQ ID NO: 9; The nucleotide sequence of the recombinant plasmid for knocking out the GGTA1, β4GalNT2, and CMAH genes in the pig genome is shown in SEQ ID NO: 10; (2) Based on the piggyBac transposon system, humanized gene transfer expression vectors of hCD39, hCD46, hCD55, hCD59, and hTBM were constructed, and the nucleotide sequence thereof is shown in SEQ ID NO:18; (3) Based on the CRISPR / Cas9 gene editing system, a secondary editing GGTA1 gene sgRNA targeting vector was constructed and connected to the backbone vector PX458-sgRNA-EGFP, whose gene sequence number is: Addgene no: 112220; The GGTA1 gene sgRNA targeting vector includes GGTA1-sgRNA3 and GGTA1-sgRNA4; the nucleotide sequence of GGTA1-sgRNA3 is shown in SEQ ID NO:3, and the nucleotide sequence of GGTA1-sgRNA4 is shown in SEQ ID NO:4; the nucleotide sequence of the recombinant plasmid for knocking out the GGTA1 gene in the pig genome is shown in SEQ ID NO:19; (4) Based on the piggyBac transposon system, hCD47 and hEPCR humanized gene transfer expression vectors were constructed, and the nucleotide sequence thereof is shown in SEQ ID NO:20; (5) Construction of GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR+ gene-edited porcine fetal fibroblast cell line 1) The recombinant plasmids for knocking out the GGTA1, β4GalNT2, and CMAH genes in the pig genome and the humanized genes of hCD39, hCD46, hCD55, hCD59, and hTBM were transferred into expression vectors and co-transfected into wild-type porcine fetal fibroblast cell lines under the action of transposase. After monoclonal cell genotype identification, the eight-gene-edited porcine fibroblast cell line GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM was screened and obtained. Somatic cell nuclear transplantation was performed using these cells as donor cells to construct the eight-gene-edited porcine fetus GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM and establish a fibroblast cell line. 2) The recombinant plasmid for knocking out the GGTA1 gene in the pig genome and the humanized genes of hCD47 and hEPCR were transferred into the expression vector and co-transfected into the eight-gene-edited porcine fetal fibroblast cell line GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD55 / hCD59 / hTBM under the action of transposase. After single-cell cloning genotype identification, the ten-gene-edited porcine fetal fibroblast cell line GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR was obtained; (6) Somatic cell nuclear transfer and embryo transfer Using GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR+gene-edited porcine fetal fibroblast cell line as donor cells, somatic cell nuclear transplantation was performed to construct GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR+gene-edited cloned embryos, which were further transplanted into estrus surrogate sows for development, and GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR+gene-edited cloned pigs were obtained by pregnancy and delivery, or the fetuses were removed during pregnancy for genotype identification and establishment of fibroblast cell lines; (7) Genotyping and phenotypic analysis of cloned pigs The genomic DNA of cloned piglets was extracted, and the genotype of cloned piglets was identified by PCR, T7ENI, and Sanger sequencing techniques. The gene mRNA and protein expression levels in cloned piglet tissues and organs were detected by Western blotting, immunofluorescence staining, flow cytometry, HE staining, and cross-matching experimental molecular biology techniques, and GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR ten gene-edited cloned pigs were obtained; (8) Through continuous cloning technology, GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR ten gene-edited cloned pigs can be mass-produced.
4. The method for constructing a ten-gene-edited xenotransplantation donor pig according to claim 3, characterized in that: The transfection method described in step (5) includes liposome transfection or electrofection.
5. The GTKO / β4GalNT2KO / CMAHKO / hCD39 / hCD46 / hCD47 / hCD55 / hCD59 / hTBM / hEPCR ten-gene-edited porcine fetal fibroblast cell line according to any one of claims 1-2 or the method for constructing a ten-gene-edited xenotransplantation donor pig according to claim 3 is used in the field of biomedical research.
Citation Information
Cited By
Eleven-gene edited porcine fibroblast line, construction method and application
CN121160634A
